Efforts are being made to produce therapeutic vaccines that will suppress the formation of premalignant lesions and cancers in women already infected with high-risk HPVs. The research underway however has not produced encouraging results yet.
Efforts are being made to produce therapeutic vaccines that will suppress the formation of premalignant lesions and cancers in women already infected with high-risk HPVs. The research underway however has not produced encouraging results yet.